6 results about "Tocopheryl phosphate" patented technology

The invention belongs to the technical field of cosmetics, and discloses a vitamin E emulsion and a preparation method thereof, the vitamin E emulsion comprises the following components by mass: 0.5-2 wt% of vitamin E and derivatives thereof, 10-20 wt% of a stabilizer, 10-20 wt% of a humectant, 3-6 wt% of an emulsifier, 0.3-1 wt% of a thickener, 0.5-1 wt% of a preservative, and the balance of water; wherein the vitamin E and the derivative thereof comprise at least one of vitamin E, tocopheryl acetate, tocopheryl linoleate, tocopheryl nicotinate and tocopheryl phosphate; the stabilizer comprises at least one of petrolatum, polydimethylsiloxane, hydrogenated polyisobutene, caprylic / capric triglyceride and butyrospermum parkii butter. Through the components, the antioxidant activity of vitamin E in the storage and skin retention process of the vitamin E milk can be effectively maintained.

The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.

To provide a cosmetic composition containing γ-tocopheryl phosphate that is transparent while suppressing the formation of insoluble crystals over time. [Solution] A cosmetic composition containing γ-tocopheryl phosphate or a salt thereof, further comprising (a) at least one base selected from a predetermined group and / or (b) at least one polymer selected from a predetermined group, wherein the content of oily components is less than a predetermined upper limit based on the total amount of the composition.

The invention relates to an oral cannabinoid formulation comprising: a cannabinoid component comprising a cannabinoid; a carrier in the form of long chain triglyceride (LCT) or long chain fatty acid (LCFA); and a tocopheryl phosphate component comprising mono-(tocopheryl) phosphate (TP) and di-(tocopheryl) phosphate (T2P) wherein the mass ratio of the cannabinoid to the tocopheryl phosphate component is about 10:1 to 1:10.

The present invention relates to an oral cannabinoid formulation comprising a cannabinoid component and a tocopheryl phosphate component, wherein the cannabinoid component comprises a cannabinoid and a carrier in the form of a long-chain triglyceride (LCT) or a long-chain fatty acid (LCFA), the tocopheryl phosphate component comprises mono(tocopheryl) phosphate (TP) and di(tocopheryl) phosphate (T2P), and the mass ratio of the cannabinoid to the tocopheryl phosphate component is between about 10:1 and 1:10.